Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Sierra MS"'
Autor:
Jarod T. Griffin MD, David C. Landy MD, PhD, Charles A. Mechas MD, Mark R. Nazal MD, MPH, Jeffrey A. Foster MD, Wyatt G.S. Southall BS, Maaz Muhammad MD, Carlos R. Sierra MS, BS, Eric S. Moghadamian MD, Arjun Srinath MD, FAAOS, MPH, Arun Aneja MD, PhD
Publikováno v:
Foot & Ankle Orthopaedics, Vol 9 (2024)
Introduction/Purpose: Avascular necrosis (AVN) is a complication of talar neck fractures associated with chronic pain and poor functional outcomes. Hawkins sign, the radiographic presence of subchondral lucency seen in the talar dome 6 to 8 weeks aft
Externí odkaz:
https://doaj.org/article/4d074d8dac014963962cbb004998f2cf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Porras C; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Romero B; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Kemp T; Frederick National Laboratory, Frederick, MD, USA., Fantin R; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Herrero R; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Hildesheim A; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Ocampo R; Agencia Costarricense de Investigaciones Biomédicas, San José, Costa Rica., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Gail MH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Schussler J; Information Management Services, Silver Spring, MD, USA., Schiller JT; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Lowy DR; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Pinto LA; Frederick National Laboratory, Frederick, MD, USA., Liu D; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Publikováno v:
Journal of the National Cancer Institute. Monographs [J Natl Cancer Inst Monogr] 2024 Nov 01; Vol. 2024 (67), pp. 329-336.
Autor:
Pérez-Lamas L; Hospital Universitario Puerta de Hierro, Madrid, Spain., Díaz AS; Hospital Universitario de Gran Canaria Doctor Negrín, Gran Canaria, Spain., Casterá EM; Hospital Universitario y Politécnico La Fe, Valencia, Spain., Soto MH; Hospital Universitario Vall d´Hebron, Barcelona, Spain., Coll AP; Hospital Universitario Puerto Real, Puerto Real, Spain., De Las Heras N; Hospital Universitario de León, León, Spain., Cortes M; Hospital General de Granollers, Barcelona, Spain., Tenza PV; Hospital Del Mar, Barcelona, Spain., Pacho MS; Hospital Clínico Universitario de Salamanca, Salamanca, Spain., Magan AS; Hospital Duran i Reynals-ICO, Barcelona, Spain., Angona A; Hospital Universitario Dr. J Trueta - ICO, Girona, Spain., Cervero C; Hospital Virgen de la Luz, Cuenca, Spain., de Paz R; Hospital Universitario La Paz, Madrid, Spain., Cuenca AS; Hospital de Jerez de la Frontera, Jerez de la Frontera, Spain., Santaliestra M; Hospital Universitari Mútua Terrassa, Barcelona, Spain., Marín JL; Hospital General de Alicante, Alicante, Spain., Casado LF; Hospital Virgen de la Salud, Toledo, Spain., García-Gutiérrez V; Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Universidad de Alcalá, Madrid, Spain. jvalentingg@gmail.com.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Nov; Vol. 103 (11), pp. 4537-4544. Date of Electronic Publication: 2024 Sep 13.
Autor:
Slimovitch R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA., Shing JZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Fantin R; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Vanegas JC; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Porras C; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Herrero R; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica., Shiels MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Stephens ES; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Calderón A; Caja Costarricense de Seguro Social, Proyecto de Fortalecimiento de la Atención del Cáncer, San José, Costa Rica., Carvajal LJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.; Agencia Costarricense de Investigaciones Biomédicas (ACIB-FUNIN), Formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica.
Publikováno v:
Lancet regional health. Americas [Lancet Reg Health Am] 2024 Aug 27; Vol. 38, pp. 100872. Date of Electronic Publication: 2024 Aug 27 (Print Publication: 2024).
Autor:
Fantin R; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica; Centro Centroamericano de Población, Universidad de Costa Rica, Costa Rica. Electronic address: rfantin@acibfunin.com., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Vaccarella S; International Agency for Research on Cancer (IARC), Lyon, France., Herrero R; Agencia Costarricense de Investigaciones Biomédicas, Fundación INCIENSA, San José, Costa Rica., Barboza-Solís C; Facultad de Odontología, Universidad de Costa Rica, Costa Rica. Electronic address: cristina.barbozasolis@ucr.ac.cr.
Publikováno v:
Cancer epidemiology [Cancer Epidemiol] 2024 Aug; Vol. 91, pp. 102604. Date of Electronic Publication: 2024 Jun 27.
Autor:
Montero SS; Nefrología, University Assistance Complex of Leon, León, Spain. Electronic address: sisanchezm@mail.ucv.es., Guix EM; Nefrología, University Assistance Complex of Leon, León, Spain., Ausín MS; Nefrología, University Assistance Complex of Leon, León, Spain., García FI; Nefrología, University Assistance Complex of Leon, León, Spain., Gómez BL; Nefrología, University Assistance Complex of Leon, León, Spain., Martinez-Rosero CV; Nefrología, University Assistance Complex of Leon, León, Spain., Guerrero XYM; Nefrología, University Assistance Complex of Leon, León, Spain., Zaldumbide EJR; Nefrología, University Assistance Complex of Leon, León, Spain., Velasco MAP; Nefrología, University Assistance Complex of Leon, León, Spain., Alvarez CL; Nefrología, University Assistance Complex of Leon, León, Spain., Lopez AS; Nefrología, University Assistance Complex of Leon, León, Spain., Kasabji GE; Nefrología, University Assistance Complex of Leon, León, Spain.
Publikováno v:
Nefrologia [Nefrologia (Engl Ed)] 2024 Jul-Aug; Vol. 44 (4), pp. 599-601. Date of Electronic Publication: 2024 Aug 20.
Autor:
Magro-Lopez E; Molecular Immuno-Biology Laboratory, Immunology Section, Hospital General Universitario Gregorio Marañón (HGUGM), Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Vazquez-Alejo E; Molecular Immuno-Biology Laboratory, Immunology Section, Hospital General Universitario Gregorio Marañón (HGUGM), Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Espinar-Buitrago MS; Molecular Immuno-Biology Laboratory, Immunology Section, Hospital General Universitario Gregorio Marañón (HGUGM), Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain., Muñoz-Fernández MÁ; Molecular Immuno-Biology Laboratory, Immunology Section, Hospital General Universitario Gregorio Marañón (HGUGM), Madrid, Spain.; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.; Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Publikováno v:
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2024 Jun 03; Vol. 12, pp. 1395723. Date of Electronic Publication: 2024 Jun 03 (Print Publication: 2024).
Autor:
Kamuyu G; Virus Reference Department, Public Health Microbiology Division, UK Health Security Agency, London, UK., Coelho da Silva F; Virus Reference Department, Public Health Microbiology Division, UK Health Security Agency, London, UK., Tenet V; International Agency for Research on Cancer (IARC/WHO) Early Detection, Prevention and Infections Branch, Lyon, France., Schussler J; Information Management Services Inc, Silver Spring, MD, USA., Godi A; Virus Reference Department, Public Health Microbiology Division, UK Health Security Agency, London, UK., Herrero R; Agencia Costarricense de Investigaciones Biomédicas (ACIB) formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA (FUNIN), San José, Costa Rica., Porras C; Agencia Costarricense de Investigaciones Biomédicas (ACIB) formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA (FUNIN), San José, Costa Rica., Mirabello L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Schiller JT; Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Sierra MS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Kreimer AR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Clifford GM; International Agency for Research on Cancer (IARC/WHO) Early Detection, Prevention and Infections Branch, Lyon, France., Beddows S; Virus Reference Department, Public Health Microbiology Division, UK Health Security Agency, London, UK. simon.beddows@ukhsa.gov.uk.; Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division, UK Health Security Agency, London, UK. simon.beddows@ukhsa.gov.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Feb 21; Vol. 15 (1), pp. 1608. Date of Electronic Publication: 2024 Feb 21.
Autor:
Espinar-Buitrago MS; Section of Immunology, Immuno-Molecular Biology Laboratory (LIBM), University General Hospital Gregorio Marañon (HGUGM), 28007 Madrid, Spain.; Gregorio Marañon Health Research Institute (IiSGM), 28009 Madrid, Spain.; Center for Biomedical Research in Bioengineering, Biomaterials and Nanotechnology Network (CIBER-BBN), 28029 Madrid, Spain., Magro-López E; Section of Immunology, Immuno-Molecular Biology Laboratory (LIBM), University General Hospital Gregorio Marañon (HGUGM), 28007 Madrid, Spain.; Gregorio Marañon Health Research Institute (IiSGM), 28009 Madrid, Spain.; Center for Biomedical Research in Bioengineering, Biomaterials and Nanotechnology Network (CIBER-BBN), 28029 Madrid, Spain., Vázquez-Alejo E; Section of Immunology, Immuno-Molecular Biology Laboratory (LIBM), University General Hospital Gregorio Marañon (HGUGM), 28007 Madrid, Spain.; Gregorio Marañon Health Research Institute (IiSGM), 28009 Madrid, Spain.; Center for Biomedical Research in Bioengineering, Biomaterials and Nanotechnology Network (CIBER-BBN), 28029 Madrid, Spain., Muñoz-Fernández MÁ; Section of Immunology, Immuno-Molecular Biology Laboratory (LIBM), University General Hospital Gregorio Marañon (HGUGM), 28007 Madrid, Spain.; Gregorio Marañon Health Research Institute (IiSGM), 28009 Madrid, Spain.; Center for Biomedical Research in Bioengineering, Biomaterials and Nanotechnology Network (CIBER-BBN), 28029 Madrid, Spain.; HIV-HGM Biobank, University General Hospital Gregorio Marañon (HGUGM), 28007 Madrid, Spain.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 06; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 06.